Search Results 531-540 of 21195 for anti-TNF drugs

1. Milk thistle - Mayo Clinic

   Milk thistle may affect how your liver processes this osteoporosis medication, causing higher levels of the drug in your bloodstream. Talk to your doctor before ...

2. Mayo Clinic Health Letter: Highlights from the March 2015 Issue

   Anti-seizure medications can help reduce this activity and decrease pain levels. Nonmedication strategies ― Using drugs to manage chronic pain usually works ...

3. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

   Patient is currently receiving anti-TNF treatment for ≤12 months. Patient must receive anti-TNF treatment within 2 months following enrollment into the ...

4. An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors - Mayo Clinic

   Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell ...

5. Secukinumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Secukinumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) ...

6. Levoketoconazole (Oral Route) Before Using - Mayo Clinic

   Your doctor may decide not to treat you with this medication or change some of the other medicines you take. ... Adalimumab; Albendazole; Allopurinol; Alprazolam ...

7. Triamterene And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. Antimyasthenic (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

   These medicines are available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release; Solution ...

9. Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation - Mayo Clinic

   Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage ...

10. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...